<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>
<HEAD>
<TITLE>Converted by EDGARwiz</TITLE>
</HEAD>
<BODY style="margin-top:0;font-family:Times New Roman; font-size:10pt; color:#000000">
<DIV style="width:624px"><P style="margin:0px" align=center><B>UNITED STATES </B></P>
<P style="margin:0px" align=center><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P style="margin:0px" align=center><B>Washington, D.C. 20549 </B></P>
<P style="margin:0px">&#160; </P>
<P style="margin:0px" align=center>____________________________________________________________ </P>
<P style="margin:0px">&#160; </P>
<P style="margin:0px; font-size:12pt" align=center><B>FORM 8-K </B></P>
<P style="margin:0px">&#160; </P>
<P style="margin:0px; font-size:12pt" align=center><B>CURRENT REPORT </B></P>
<P style="margin:0px">&#160; </P>
<P style="margin:0px" align=center>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 </P>
<P style="margin:0px">&#160; </P>
<P style="margin:0px" align=center>___________________________________________________________________ </P>
<P style="margin:0px">&#160; </P>
<P style="margin:0px" align=center>Date of Report (Date of earliest event reported):&#160;&#160;December 18, 2012 </P>
<P style="margin:0px">&#160; </P>
</DIV><TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0><TR height=0 style="font-size:0"><TD width=282.533 /><TD width=162.667 /><TD width=207.667 /></TR>
<TR><TD style="margin-top:0px; border-bottom:2px solid #000000" valign=bottom width=652.867 height=22 colspan=3><P style="margin:0px; font-size:12pt" align=center><B>BioCube, Inc.</B></P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=652.867 height=21 colspan=3><P style="margin:0px" align=center>(Exact name of registrant as specified in its charter) </P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=652.867 height=30 colspan=3><P style="margin:0px" align=center>(Former name if changed since last report) </P>
</TD></TR>
<TR><TD style="margin-top:0px; border-bottom:2px solid #000000" valign=bottom width=282.533 height=22><P style="margin:0px" align=center>Delaware </P>
</TD><TD style="margin-top:0px; border-bottom:2px solid #000000" valign=bottom width=162.667 height=22><P style="margin:0px" align=center>333-137920 </P>
</TD><TD style="margin-top:0px; border-bottom:2px solid #000000" valign=bottom width=207.667 height=22><P style="margin:0px" align=center>20-3547389 </P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=282.533 height=8.8><P style="margin:0px" align=center>(State or other jurisdiction of incorporation) </P>
</TD><TD style="margin-top:0px" valign=bottom width=162.667 height=8.8><P style="margin:0px" align=center>(Commission File Number) &nbsp;</P>
</TD><TD style="margin-top:0px" valign=bottom width=207.667 height=8.8><P style="margin:0px" align=center>(IRS Employer Identification No.) &nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-bottom:2px solid #000000" valign=bottom width=282.533 height=46.8><P style="margin:0px" align=center>1365 N. Courtenay Parkway, Suite A Merritt Island, FL</P>
</TD><TD style="margin-top:0px; border-bottom:2px solid #000000" valign=bottom width=162.667 height=46.8><P style="margin:0px; font-size:12pt">&#160;</P>
</TD><TD style="margin-top:0px; border-bottom:2px solid #000000" valign=bottom width=207.667 height=46.8><P style="margin:0px" align=center>32953</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=282.533 height=21><P style="margin:0px" align=center>(Registrant<font style='font-family:Arial Unicode MS,Times New Roman'>&#8217;</font>s address)</P>
</TD><TD style="margin-top:0px" valign=bottom width=162.667 height=21><P style="margin:0px"><BR></P>
</TD><TD style="margin-top:0px" valign=bottom width=207.667 height=21><P style="margin:0px" align=center>(Zip Code) </P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=bottom width=652.867 height=25.2 colspan=3><P style="margin:0px" align=center>Registrant<font style='font-family:Arial Unicode MS,Times New Roman'>&#8217;</font>s telephone number, including area code: (321)-452-9091 </P>
</TD></TR>
</TABLE>
<DIV style="width:624px"><P style="margin:0px"><BR></P>
<P style="margin:0px">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </P>
<P style="margin:0px">&#160; </P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 width=100%><TR height=0 style="font-size:0"><TD width=13.333 /><TD /></TR>
<TR><TD style="margin-top:0px" valign=top width=13.333><P style="margin:0px; font-family:Wingdings">o </P>
</TD><TD style="margin-top:0px" valign=top><P style="margin:0px">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </P>
</TD></TR>
</TABLE>
<P style="margin:0px">&#160; </P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 width=100%><TR height=0 style="font-size:0"><TD width=13.333 /><TD /></TR>
<TR><TD style="margin-top:0px" valign=top width=13.333><P style="margin:0px; font-family:Wingdings">o </P>
</TD><TD style="margin-top:0px" valign=top><P style="margin:0px">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </P>
</TD></TR>
</TABLE>
<P style="margin:0px">&#160; </P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 width=100%><TR height=0 style="font-size:0"><TD width=13.333 /><TD /></TR>
<TR><TD style="margin-top:0px" valign=top width=13.333><P style="margin:0px; font-family:Wingdings">o </P>
</TD><TD style="margin-top:0px" valign=top><P style="margin:0px">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </P>
</TD></TR>
</TABLE>
<P style="margin:0px">&#160; </P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 width=100%><TR height=0 style="font-size:0"><TD width=13.333 /><TD /></TR>
<TR><TD style="margin-top:0px" valign=top width=13.333><P style="margin:0px; font-family:Wingdings">o </P>
</TD><TD style="margin-top:0px" valign=top><P style="margin:0px">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </P>
</TD></TR>
</TABLE>
<P style="margin:0px">&#160; </P>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=center>&#160; </P>
<P style="margin-top:0px; margin-bottom:11.133px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
<P style="margin:0px; font-size:11pt" align=center>0</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; page-break-before:always"><B>Section 1 <font style='font-family:Arial Unicode MS,Times New Roman'>&#8211;</font> Registrant<font style='font-family:Arial Unicode MS,Times New Roman'>&#8217;</font>s Business and Operations</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><B>Item 1.01 Entry into a Material Definitive Agreement</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:48px">On December 17, 2012, Registrant entered into an agreement with Li-Ion Technologies Limited, a Russian limited liability company(<font style='font-family:Arial Unicode MS,Times New Roman'>&#8220;</font>Liotech<font style='font-family:Arial Unicode MS,Times New Roman'>&#8221;</font>) with its principal office located in Moscow and production facilities located in Novosibirsk, Russia, granting BioCube the right to market and distribute batteries in the North American market utilizing the Liotech proprietary and patented process. </P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:48px; font-size:11pt">&#160;<FONT style="font-size:10pt">Liotech</FONT><FONT style="font-size:10pt"> has developed a revolutionary lithium ion battery for use in conventional power plants, renewable energy systems, industrial uninterruptable power supply devices, network energy storage and other commercial and household energy storage related uses. &nbsp;</FONT><FONT style="font-size:10pt">Liotech</FONT><FONT style="font-size:10pt">, one of the largest Li-Ion batteries manufacturers in the world with total annual production capacity of 1.4GWh</FONT><FONT style="font-size:10pt">,</FONT><FONT style="font-size:10pt"> was created in 2010 to further </FONT><FONT style="font-size:10pt">the </FONT><FONT style="font-size:10pt">development of lithium-ion battery technologies for use as energy storage in conventional and solar/wind power applications, electrical vehicles and uninterrupted power supplies.</FONT><FONT style="font-size:10pt">U</FONT><FONT style="font-size:10pt">tilizing </FONT><FONT style="font-size:10pt">its </FONT><FONT style="font-size:10pt">recently announced </FONT><FONT style="font-size:10pt">GreenSync</FONT><FONT style="font-size:10pt"> Solutions platform, </FONT><FONT style="font-size:10pt">BioCube</FONT><FONT style="font-size:10pt"> </FONT><FONT style="font-size:10pt">will distribute </FONT><FONT style="font-size:10pt">Liotech</FONT><FONT style="font-size:10pt"> batteries and battery management systems in North America, initially to companies in the solar and wind power generation, followed by marine equipment and electrical vehicles producers.</FONT></P>
<P style="margin:0px" align=center><B>SIGNATURES </B></P>
<P style="margin:0px">&#160; </P>
<P style="margin:0px; text-indent:48px">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. &#160;</P>
<P style="margin:0px; text-indent:48px">&nbsp;</P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0><TR height=0 style="font-size:0"><TD width=177.533 /><TD width=13.867 /><TD width=108.667 /><TD width=33.267 /></TR>
<TR><TD style="margin-top:0px" valign=top width=177.533 height=32.333><P style="margin:0px">&#160; </P>
</TD><TD style="margin-top:0px" valign=top width=122.533 height=32.333 colspan=2><P style="margin:0px"><B>BIOCUBE, INC. </B></P>
</TD><TD style="margin-top:0px" valign=top width=33.267 height=32.333><P style="margin:0px">&#160; </P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=177.533 height=16.667><P style="margin:0px">&#160; </P>
</TD><TD style="margin-top:0px" valign=top width=13.867 height=16.667><P style="margin:0px">&#160; </P>
</TD><TD style="margin-top:0px" valign=top width=108.667 height=16.667><P style="margin:0px">&#160; </P>
</TD><TD style="margin-top:0px" valign=top width=33.267 height=16.667><P style="margin:0px">&#160; </P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=177.533 height=15.667><P style="margin:0px">Date: December 18, 2012</P>
</TD><TD style="margin-top:0px" valign=top width=13.867 height=15.667><P style="margin:0px">By: </P>
</TD><TD style="margin-top:0px; border-bottom:1px solid #000000" valign=top width=108.667 height=15.667><P style="margin:0px"><U>/s/&#160;Boris Rubizhevsky&#160;&#160;&#160;&#160; </U></P>
</TD><TD style="margin-top:0px" valign=top width=33.267 height=15.667><P style="margin:0px">&#160; </P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=177.533 height=15.667><P style="margin:0px">&#160; </P>
</TD><TD style="margin-top:0px" valign=top width=13.867 height=15.667><P style="margin:0px">&#160; </P>
</TD><TD style="margin-top:0px" valign=bottom width=108.667 height=15.667><P style="margin:0px">Boris Rubizhevsky&#160;&#160;&#160;&#160; </P>
</TD><TD style="margin-top:0px" valign=top width=33.267 height=15.667><P style="margin:0px">&#160; </P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=177.533 height=16.667><P style="margin:0px">&#160; </P>
</TD><TD style="margin-top:0px" valign=top width=13.867 height=16.667><P style="margin:0px">&#160; </P>
</TD><TD style="margin-top:0px" valign=top width=108.667 height=16.667><P style="margin:0px">Chief Executive and Financial Officer </P>
</TD><TD style="margin-top:0px" valign=top width=33.267 height=16.667><P style="margin:0px"><BR></P>
</TD></TR>
</TABLE>
<P style="margin-top:0px; margin-bottom:12.2px"><BR></P>
<P style="margin-top:0px; margin-bottom:12.2px"><BR>
<BR></P>
<P style="margin:0px; font-size:11pt" align=center>1</P>
<P style="margin:0px"><BR></P>
</DIV></BODY>
<!-- EDGAR Validation Code: 58B9F762 -->
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "r8kliotech12182012.htm", "description": "BIOCUBE FORM 8-K LIOTECH AGREEMENT", "secsgml_size_bytes": 12311}]
{"company-data": {"conformed-name": "BioCube, INC.", "cik": "0001374135", "assigned-sic": "4522", "irs-number": "203547389", "state-of-incorporation": "DE", "fiscal-year-end": "1220"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-35227", "film-number": "121272161"}, "business-address": {"street1": "1365 N. COURTENAY PARKWAY", "street2": "SUITE A", "city": "MERRITT ISLAND", "state": "FL", "zip": "32953", "phone": "321-452-9091"}, "mail-address": {"street1": "1365 N. COURTENAY PARKWAY", "street2": "SUITE A", "city": "MERRITT ISLAND", "state": "FL", "zip": "32953"}, "former-company": [{"former-conformed-name": "ALLIANCE NETWORK COMMUNICATIONS HOLDINGS, INC.", "date-changed": "20090827"}, {"former-conformed-name": "Halcyon Jets Holdings, Inc.", "date-changed": "20070823"}, {"former-conformed-name": "GREENLEAF FOREST PRODUCTS, INC.", "date-changed": "20060829"}]}
Converted by EDGARwiz
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________________________________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
___________________________________________________________________
Date of Report (Date of earliest event reported):  December 18, 2012
BioCube, Inc.
(Exact name of registrant as specified in its charter)
(Former name if changed since last report)
Delaware
333-137920
20-3547389
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
1365 N. Courtenay Parkway, Suite A Merritt Island, FL
32953
(Registrant
'
s address)
(Zip Code)
Registrant
'
s telephone number, including area code: (321)-452-9091
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
0
Section 1
–
Registrant
'
s Business and Operations
Item 1.01 Entry into a Material Definitive Agreement
On December 17, 2012, Registrant entered into an agreement with Li-Ion Technologies Limited, a Russian limited liability company(
"
Liotech
"
) with its principal office located in Moscow and production facilities located in Novosibirsk, Russia, granting BioCube the right to market and distribute batteries in the North American market utilizing the Liotech proprietary and patented process.
Liotech
has developed a revolutionary lithium ion battery for use in conventional power plants, renewable energy systems, industrial uninterruptable power supply devices, network energy storage and other commercial and household energy storage related uses.
Liotech
, one of the largest Li-Ion batteries manufacturers in the world with total annual production capacity of 1.4GWh
,
was created in 2010 to further
the
development of lithium-ion battery technologies for use as energy storage in conventional and solar/wind power applications, electrical vehicles and uninterrupted power supplies.
U
tilizing
its
recently announced
GreenSync
Solutions platform,
BioCube
will distribute
Liotech
batteries and battery management systems in North America, initially to companies in the solar and wind power generation, followed by marine equipment and electrical vehicles producers.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
BIOCUBE, INC.
Date: December 18, 2012
By:
/s/ Boris Rubizhevsky
Boris Rubizhevsky
Chief Executive and Financial Officer
1